Infertility Drugs Market, By Drug Type (Clomiphene citrate, Sex hormones, Gonadotropins, Bromocriptine, Cabergoline, Imipramine, Letrozole, Metformin), By Route of Administration (Oral and Parenteral), By Gender (Male and Female), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Feb 2025

Code : CMI2665

Pages :145

Formats :

Excel and PDF

Industry : Pharmaceutical

Infertility Drugs Market Size and Trends

Global infertility drugs market is estimated to be valued at USD 4.18 Bn in 2025 and is expected to reach USD 6.62 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 6.8% from 2025 to 2032.

Infertility Drugs Market Key Factors

To learn more about this report, Request sample copy

Increasing prevalence of infertility issues due to lifestyle changes, rising stress levels, and obesity can drive the global infertility drugs market. Rising healthcare expenditure, growing awareness regarding infertility treatments, technological advancements in fertility treatment techniques, and availability of reimbursement coverage for fertility treatments in developed countries can boost demand for infertility drugs. However, high cost of infertility treatment and procedures, lack of awareness in developing nations, adverse effects associated with use of fertility drugs, and social stigma related to infertility issues in certain regions can hamper the market growth during the forecast period.

Advances in Assisted Reproductive Technologies

In recent years, there have been significant advancements in assisted reproductive technologies for treating infertility issues. Technologies such as IVF, ICSI, and surrogacy have enabled many couples to fulfill their dreams of having children. Success rates of IVF cycles have improved due to better understanding of human reproductive biology as well as refinements in laboratory procedures. Furthermore, egg freezing has emerged as a viable option for women looking to delay pregnancy but preserve their fertility. This has especially benefited women focusing on their careers. The availability of these technologies in standard fertility clinics and IVF centers across major cities has made them accessible to more people. Growing demand for these technologies can boost need for infertility drugs that help stimulate egg production, facilitate sperm collection, prepare the endometrium, and support early pregnancy. New drugs that specifically target underlying causes of infertility are also entering the market. The continuous technological breakthroughs in this area and rising ability to pay for them in developing markets can boosts use of related fertility medications.